Tuesday, 28 December 2010

Mécillinam




Mécillinam may be available in the countries listed below.


Ingredient matches for Mécillinam



Mecillinam

Mécillinam (DCF) is also known as Mecillinam (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 27 December 2010

Salbu Easyhaler




Salbu Easyhaler may be available in the countries listed below.


Ingredient matches for Salbu Easyhaler



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbu Easyhaler in the following countries:


  • Germany

International Drug Name Search

Saturday, 25 December 2010

Lorazepam-Eurogenerics




Lorazepam-Eurogenerics may be available in the countries listed below.


Ingredient matches for Lorazepam-Eurogenerics



Lorazepam

Lorazepam is reported as an ingredient of Lorazepam-Eurogenerics in the following countries:


  • Luxembourg

International Drug Name Search

Acido Fusidico




Acido Fusidico may be available in the countries listed below.


Ingredient matches for Acido Fusidico



Fusidic Acid

Acido Fusidico (DCIT) is known as Fusidic Acid in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Friday, 24 December 2010

Tonsillitis/Pharyngitis Medications


Drugs associated with Tonsillitis/Pharyngitis

The following drugs and medications are in some way related to, or used in the treatment of Tonsillitis/Pharyngitis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Tonsillitis/Pharyngitis





Drug List:

Rowasa rectal


Generic Name: mesalamine (rectal) (me SAL a meen)

Brand Names: Canasa, Canasa Pac, Rowasa


What is Rowasa (mesalamine (rectal))?

Mesalamine affects a substance in the body that causes inflammation, tissue damage, and diarrhea.


Mesalamine rectal is used to treat ulcerative colitis, proctitis, and proctosigmoiditis. Mesalamine is also used to prevent the symptoms of ulcerative colitis from recurring.


Mesalamine rectal may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Rowasa (mesalamine (rectal))?


Do not take mesalamine rectal by mouth. It is for use only in your rectum. Tell your doctor if you have any type of kidney or liver disease, or if you are allergic to aspirin. You may not be able to use mesalamine, or you may need a dosage adjustment or special tests during treatment.

This medication comes with patient instructions for using either the rectal suppository or the rectal enema. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Try to empty your bowel and bladder just before using the mesalamine suppository or enema. Try to use the medicine at a time when you can lie down afterward and hold the medicine in. Avoid using the bathroom during this time. It may be best to use this medicine at bedtime.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Shake the rectal enema liquid well just before each use.

The rectal enema liquid may darken in color after it has been removed from the foil pouch. This should not affect the medicine. However, throw away any enema liquid that has turned dark brown.


Stop using mesalamine and call your doctor at once if you have severe stomach pain, cramping, fever, headache, and bloody diarrhea.

Avoid getting the rectal suppositories or enema liquid on clothing, flooring, painted surfaces, vinyl, marble, granite, and other surfaces. Mesalamine rectal products may stain surfaces.


What should I discuss with my health care provider before taking Rowasa (mesalamine (rectal))?


Tell your doctor if you have any type of kidney or liver disease, or if you are allergic to aspirin. You may not be able to use mesalamine, or you may need a dosage adjustment or special tests during treatment. FDA pregnancy category B. This medication is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Mesalamine rectal can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I use Rowasa (mesalamine (rectal))?


Use this medication exactly as it was prescribed for you. Do not use the medication in larger or smaller amounts, or use it for longer than recommended by your doctor.


Mesalamine rectal comes with patient instructions for using either the rectal suppository or the rectal enema. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


Do not take mesalamine rectal by mouth. It is for use only in your rectum.

Try to empty your bowel and bladder just before using the mesalamine suppository or enema. It may be best to use this medicine at bedtime.


Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


For best results from the suppository, lie down after inserting it and hold in the suppository for one to three hours. The suppository will melt quickly once inserted and you should feel little or no discomfort while holding it in. Avoid using the bathroom during this time.


Shake the rectal enema liquid well just before each use.

For best results from the enema, stay lying down for at least 30 minutes after using the enema to allow the liquid to distribute throughout your intestines. Try to hold in the enema all night if possible. Avoid using the bathroom during this time.


The rectal enema liquid may darken in color after it has been removed from the foil pouch. This should not affect the medicine. However, throw away any enema liquid that has turned dark brown.


Store the rectal enema at room temperature away from moisture and heat. Store the rectal suppositories at cool room temperature away from moisture and heat. Do not refrigerate or freeze them.

What happens if I miss a dose?


Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Try to use the medicine at a time when you can lie down afterward and hold the medicine in. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of mesalamine rectal is not expected to produce life-threatening symptoms.

What should I avoid while taking Rowasa (mesalamine (rectal))?


Avoid getting the rectal suppositories or enema liquid on clothing, flooring, painted surfaces, vinyl, marble, granite, and other surfaces. Mesalamine rectal products may stain surfaces.


Rowasa (mesalamine (rectal)) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using mesalamine rectal and call your doctor at once if you have severe stomach pain, cramping, fever, headache, and bloody diarrhea.

Less serious side effects may include:



  • mild nausea, vomiting, stomach cramps, diarrhea, gas;




  • fever, sore throat, or other flu symptoms;




  • rectal pain, constipation;




  • headache or dizziness;




  • tired feeling; or




  • skin rash.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Rowasa (mesalamine (rectal))?


There may be other drugs that can interact with mesalamine rectal. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Rowasa resources


  • Rowasa Side Effects (in more detail)
  • Rowasa Use in Pregnancy & Breastfeeding
  • Rowasa Drug Interactions
  • Rowasa Support Group
  • 5 Reviews for Rowasa - Add your own review/rating


Compare Rowasa with other medications


  • Crohn's Disease
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Ulcerative Colitis, Active
  • Ulcerative Proctitis


Where can I get more information?


  • Your pharmacist can provide more information about mesalamine rectal.

See also: Rowasa side effects (in more detail)


Thursday, 23 December 2010

Nevralgin




Nevralgin may be available in the countries listed below.


Ingredient matches for Nevralgin



Metamizole

Metamizole sodium anhydrous (a derivative of Metamizole) is reported as an ingredient of Nevralgin in the following countries:


  • Romania

International Drug Name Search

Wednesday, 22 December 2010

Telebrix Meglumine




Telebrix Meglumine may be available in the countries listed below.


Ingredient matches for Telebrix Meglumine



Ioxitalamic Acid

Ioxitalamic Acid meglumine (a derivative of Ioxitalamic Acid) is reported as an ingredient of Telebrix Meglumine in the following countries:


  • Czech Republic

  • Luxembourg

International Drug Name Search

Monday, 20 December 2010

Mizollen




Mizollen may be available in the countries listed below.


UK matches:

  • Mizollen 10 mg modified- release tablets (SPC)

Ingredient matches for Mizollen



Mizolastine

Mizolastine is reported as an ingredient of Mizollen in the following countries:


  • Belgium

  • France

  • Germany

  • Greece

  • Israel

  • Italy

  • Luxembourg

  • Netherlands

  • Poland

  • Portugal

  • South Africa

  • Sweden

  • Switzerland

  • Taiwan

  • Tunisia

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, 19 December 2010

Epoetin Delta




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B03XA01

CAS registry number (Chemical Abstracts Service)

0261356-80-3

Chemical Formula

C809-H1301-N229-O240-S5

Molecular Weight

18236

Therapeutic Categories

Antianemic agent

Hematopoietic growth factor

Chemical Name

1-165-erythropoietin (human HMR4396), glycoform delta (WHO)

Foreign Names

  • Epoetinum Delta (Latin)
  • Epoetin Delta (German)
  • Epoétine Delta (French)
  • Epoetina Delta (Spanish)

Generic Names

  • Epoetin Delta (OS: USAN)
  • GA-EPO (IS: Aventis)
  • HMR-4396 (IS)
  • MDL-104396 (IS)

Brand Names

  • Dynepo
    Shire, Greece; Shire, Slovakia

International Drug Name Search

Glossary

ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 14 December 2010

Travelmin




Travelmin may be available in the countries listed below.


Ingredient matches for Travelmin



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Travelmin in the following countries:


  • Argentina

Diphenhydramine

Diphenhydramine is reported as an ingredient of Travelmin in the following countries:


  • Japan

Diprophylline

Diprophylline is reported as an ingredient of Travelmin in the following countries:


  • Japan

International Drug Name Search

Monday, 13 December 2010

Propranolol AccordHealthcare




Propranolol AccordHealthcare may be available in the countries listed below.


Ingredient matches for Propranolol AccordHealthcare



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Propranolol AccordHealthcare in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 5 December 2010

Hesmin




Hesmin may be available in the countries listed below.


Ingredient matches for Hesmin



Diosmin

Diosmin is reported as an ingredient of Hesmin in the following countries:


  • Indonesia

Hesperidin

Hesperidin is reported as an ingredient of Hesmin in the following countries:


  • Indonesia

International Drug Name Search

Thursday, 2 December 2010

Riohard




Riohard may be available in the countries listed below.


Ingredient matches for Riohard



Nisoldipine

Nisoldipine is reported as an ingredient of Riohard in the following countries:


  • Japan

International Drug Name Search